Examkin

All practice questions

4736 questions

All types4,736Multiple choice2,413Multiple select567Numeric127Matching858Ordering771
Question 3341Question →

A 58-year-old woman is brought to the emergency department by her husband due to a 3-day history of increasing confusion, sluggishness, and tremors. Her husband reports that she has been sleeping more than usual and has had difficulty holding a glass of water without spilling it. Her medical history is significant for bipolar I disorder, for which she has been stable on lithium carbonate 900 mg daily for the past 5 years. She also has osteoarthritis and began taking naproxen 500 mg twice daily two weeks ago for worsening knee pain.

On physical examination, temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 14/min. She appears lethargic but is easily arousable. Neurologic examination reveals a prominent coarse, irregular tremor in her upper extremities bilaterally, as well as hyperreflexia in all four extremities. No nuchal rigidity is noted.

Serial laboratory studies are shown below:

Parameter2 Weeks AgoToday
Blood urea nitrogen14 mg/dL32 mg/dL
Serum creatinine0.9 mg/dL1.6 mg/dL
Serum lithium0.8 mEq/L2.1 mEq/L
Serum sodium140 mEq/L138 mEq/L
Serum potassium4.0 mEq/L4.2 mEq/L

An electrocardiogram shows normal sinus rhythm with no ST-segment or T-wave abnormalities.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue lithium and naproxen, and administer intravenous isotonic saline

Answer

Discontinue lithium and naproxen, and administer intravenous isotonic saline
This patient is experiencing acute-on-chronic lithium toxicity, precipitated by the addition of naproxen. NSAIDs inhibit renal prostaglandin synthesis, leading to afferent arteriolar vasoconstriction, decreased glomerular filtration rate (GFR), and a compensatory increase in the proximal tubular reabsorption of sodium and lithium. Her clinical presentation (lethargy, coarse tremor, hyperreflexia) and acute kidney injury (creatinine 1.6 mg/dL) confirm active toxicity. For lithium levels <2.5 mEq/L< 2.5 \text{ mEq/L} without life-threatening symptoms (e.g., seizures, coma), the first-line treatment is to discontinue the offending agents and administer aggressive intravenous hydration with isotonic (0.9%) saline. Saline restores intravascular volume, improves GFR, and provides a sodium load that competitively inhibits the proximal tubular reabsorption of lithium, thereby enhancing its excretion.

Step-by-Step Solution

1
Analyze the patient's medication history and recent changes.
The patient recently started naproxen, an NSAID, while on chronic lithium therapy.
NSAIDs can precipitate lithium toxicity by inhibiting renal prostaglandin synthesis, leading to decreased afferent arteriolar blood flow, decreased GFR, and increased proximal tubular reabsorption of sodium and lithium.
2
Evaluate the clinical presentation and laboratory findings.
The patient exhibits signs of acute-on-chronic lithium toxicity (lethargy, coarse tremor, hyperreflexia) alongside an acute kidney injury (creatinine elevated to 1.6 mg/dL) and a supratherapeutic serum lithium level of 2.1 mEq/L.
Determining the severity of toxicity and current renal function is critical for selecting the appropriate treatment modality.
3
Determine the indication for hemodialysis versus intravenous hydration.
Because the lithium level is <2.5 mEq/L and the patient does not have severe life-threatening neurologic symptoms (such as seizures or coma), intravenous isotonic saline is the indicated next step rather than hemodialysis.
Isotonic saline restores intravascular volume, improves GFR, and provides a sodium load that competitively inhibits the proximal tubular reabsorption of lithium, thereby enhancing its renal excretion.

Key Concept

The initial management of symptomatic lithium toxicity with a level <2.5 mEq/L involves discontinuing the offending agents (lithium and precipitants like NSAIDs, thiazides, or ACE inhibitors) and administering aggressive intravenous hydration with isotonic normal saline.
Estimated Time:1m 30s
Question 3342Question →

A 68-year-old man comes to the clinic for a 1-week follow-up after an adjustment to his heart failure medications. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 25%. One week ago, spironolactone 25 mg daily was added to his guideline-directed medical therapy regimen to further reduce morbidity and mortality. He is also taking sacubitril-valsartan, carvedilol, and dapagliflozin. The patient reports feeling well and has no shortness of breath, orthopnea, or lower extremity edema. His blood pressure is 114/72 mm Hg, and his pulse is 62/min. Physical examination reveals clear lungs and no jugular venous distention. Laboratory studies obtained today, compared to his baseline from one week ago, are shown in the table below:

Laboratory Parameter1 Week Ago (Baseline)Today
Serum sodium139 mEq/L138 mEq/L
Serum potassium4.4 mEq/L5.3 mEq/L
Blood urea nitrogen18 mg/dL22 mg/dL
Serum creatinine1.1 mg/dL1.3 mg/dL

Which of the following is the most appropriate next step in the monitoring and treatment evaluation of this patient?

Show answer & explanation

Answer: Continue the current medication regimen and repeat the basic metabolic panel in 4 weeks

Answer

Continue the current medication regimen and repeat the basic metabolic panel in 4 weeks
The correct answer is to continue the current medication regimen and repeat the basic metabolic panel in 4 weeks. This patient recently started spironolactone, a mineralocorticoid receptor antagonist (MRA). MRAs, along with other renin-angiotensin-aldosterone system (RAAS) inhibitors, commonly cause a mild increase in serum potassium and serum creatinine due to alterations in intraglomerular hemodynamics. According to current heart failure guidelines, an increase in serum creatinine of up to 30% from baseline and a rise in serum potassium up to 5.5 mEq/L are considered normal, acceptable physiological responses. This patient's creatinine increased by approximately 18% (from 1.1 to 1.3 mg/dL), and his potassium is 5.3 mEq/L. Since both parameters remain safely below the threshold for concern, the MRA should be continued at the current dose. The standard monitoring protocol for MRA initiation involves checking renal function and electrolytes at 1 week, 4 weeks, and then periodically. Therefore, the most appropriate next step is to maintain therapy and recheck the labs in 4 weeks.

Step-by-Step Solution

1
Evaluate the patient's clinical status and laboratory trends following the initiation of the mineralocorticoid receptor antagonist (spironolactone).
The patient remains asymptomatic. Serum potassium increased to 5.3 mEq/L, and serum creatinine increased from 1.1 to 1.3 mg/dL (an 18% increase).
To determine if the hemodynamic and electrolyte changes are within expected physiological limits for RAAS inhibition.
2
Compare the laboratory results against guideline-established safety thresholds.
The potassium level is below the 5.5 mEq/L threshold, and the creatinine increase is below the 30% threshold.
Changes within these limits are considered normal intraglomerular hemodynamic responses that do not warrant drug discontinuation.
3
Determine the appropriate guideline-directed monitoring interval.
Continue the current dose and schedule the next laboratory check in 4 weeks.
Because the laboratory changes represent an acceptable response without crossing toxicity thresholds, the medication should be continued to maintain its mortality benefit, with the next standard monitoring check at 4 weeks.

Key Concept

After initiating RAAS inhibitors or mineralocorticoid receptor antagonists in heart failure, an increase in serum creatinine up to 30% from baseline and a rise in serum potassium up to 5.5 mEq/L are expected physiologic responses that do not require drug discontinuation.
Estimated Time:1m 15s
Question 3343Question →

A 52-year-old man visits the clinic due to sudden, severe pain and swelling in his right big toe that began overnight. He is unable to bear weight on the affected foot. His medical history is significant for a deceased-donor renal allograft performed three years ago for end-stage renal disease secondary to hypertensive nephrosclerosis. His current medications include tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs are within normal limits. Physical examination reveals a swollen, erythematous, and exquisitely tender right first metatarsophalangeal joint. Joint aspiration is performed, and synovial fluid analysis reveals negatively birefringent, needle-shaped crystals under polarized light microscopy. His serum creatinine today is 1.6 mg/dL, which is unchanged from his baseline over the past year. Which of the following is the most appropriate pharmacologic intervention for this patient's acute joint condition?

Show answer & explanation

Answer: Intra-articular triamcinolone

Answer

Intra-articular triamcinolone is the most appropriate intervention for this patient.
Intra-articular triamcinolone is the safest and most effective therapy for acute monoarticular gout in a renal transplant recipient. By utilizing a localized injection, the physician avoids systemic drug interactions and nephrotoxicity while providing rapid, targeted symptomatic relief in a single joint.

Step-by-Step Solution

1
Analyze the clinical presentation and synovial fluid results.
The patient has an acute flare of monoarticular gout, definitively confirmed by the presence of negatively birefringent, needle-shaped crystals.
Establishing an accurate diagnosis is the essential first step before selecting targeted therapy, ruling out infectious etiologies.
2
Evaluate the patient's comorbidities and current medication list.
The patient is a renal transplant recipient with baseline chronic kidney disease, currently taking immunosuppressants including tacrolimus (a calcineurin inhibitor).
Comorbidities and immunosuppressive regimens significantly restrict standard pharmacological options due to the high risk of organ toxicity and severe drug-drug interactions.
3
Select the safest targeted therapy for acute gout based on the patient's constraints.
Intra-articular triamcinolone is chosen because standard first-line therapies (NSAIDs and colchicine) are strictly contraindicated in this specific clinical context.
NSAIDs exacerbate calcineurin inhibitor nephrotoxicity, and colchicine clearance is fatally impaired by tacrolimus-mediated P-glycoprotein and CYP3A4 inhibition. A local corticosteroid injection provides effective relief without these systemic risks.

Key Concept

Pharmacologic management of acute gout in solid organ transplant recipients requires avoiding NSAIDs (due to nephrotoxicity) and colchicine (due to severe pharmacokinetic interactions with calcineurin inhibitors), making intra-articular glucocorticoids the preferred choice for monoarticular flares.
Question 3344Question →

A hospitalist is evaluating the arterial blood gas (ABG) and metabolic panel profiles for several adult patients upon admission. Match each laboratory profile to its most likely clinical etiology. Assume a normal serum anion gap is 88-1212 mEq/L.

Click a left item, then click its matching right item

Items

pH 7.257.25, pCO2pCO_2 6060 mmHg, HCO3−HCO_3^- 2626 mEq/L. Serum Na+Na^+ 140140 mEq/L, Cl−Cl^- 105105 mEq/L.
pH 7.287.28, pCO2pCO_2 2828 mmHg, HCO3−HCO_3^- 1212 mEq/L. Serum Na+Na^+ 140140 mEq/L, Cl−Cl^- 100100 mEq/L.
pH 7.307.30, pCO2pCO_2 3030 mmHg, HCO3−HCO_3^- 1414 mEq/L. Serum Na+Na^+ 140140 mEq/L, Cl−Cl^- 114114 mEq/L.
pH 7.507.50, pCO2pCO_2 4545 mmHg, HCO3−HCO_3^- 3434 mEq/L. Urine Cl−Cl^- 1010 mEq/L.
pH 7.557.55, pCO2pCO_2 4848 mmHg, HCO3−HCO_3^- 4040 mEq/L. Urine Cl−Cl^- 5555 mEq/L.

Matches

Show answer & explanation

Answer

Laboratory profiles must be systematically evaluated by identifying the primary disturbance (pH, pCO2, HCO3-), calculating the anion gap for metabolic acidosis, and assessing urine chloride for metabolic alkalosis to find the correct etiology.
Each laboratory profile uniquely matches a clinical etiology through systematic evaluation of pH, pCO2, bicarbonate, anion gap, and urine chloride. Acute respiratory acidosis matches opiate toxicity; high anion gap metabolic acidosis matches diabetic ketoacidosis; normal anion gap metabolic acidosis matches secretory diarrhea; saline-responsive metabolic alkalosis matches emesis; and saline-resistant metabolic alkalosis matches primary hyperaldosteronism.

Step-by-Step Solution

1
Determine the primary acid-base disturbance.
Identify whether the primary process is an acidosis (pH < 7.35) or alkalosis (pH > 7.45), and whether it is metabolically (HCO3-) or respiratorily (pCO2) driven.
This categorizes the disorder into one of four primary buckets: metabolic acidosis, metabolic alkalosis, respiratory acidosis, or respiratory alkalosis.
2
Calculate the serum anion gap for cases of metabolic acidosis.
Using the formula Anion Gap = Na+ - (Cl- + HCO3-), determine if the gap is normal (8-12 mEq/L) or elevated (>12 mEq/L).
A high anion gap indicates unmeasured organic acids (e.g., ketones in DKA), while a normal gap indicates direct bicarbonate loss (e.g., diarrhea).
3
Evaluate the urine chloride concentration for cases of metabolic alkalosis.
Classify the alkalosis as saline-responsive (Urine Cl- < 20 mEq/L) or saline-resistant (Urine Cl- > 20 mEq/L).
Low urine chloride signifies volume depletion and active renal chloride retention (e.g., vomiting), whereas high urine chloride indicates mineralocorticoid excess or profound potassium depletion (e.g., hyperaldosteronism).

Key Concept

Stepwise interpretation of acid-base disorders requires identifying the primary disturbance, calculating the anion gap for metabolic acidosis, and utilizing urine chloride levels to distinguish etiologies of metabolic alkalosis.
Question 3345Question →

A 27-year-old woman, gravida 1 para 0, presents to the emergency department with two days of mild, intermittent left lower quadrant abdominal pain and light vaginal spotting. Her last menstrual period was six weeks ago. She has no significant past medical history and takes only prenatal vitamins. Vital signs include a temperature of 37.1°C (98.8°F), blood pressure of 118/74 mm Hg, heart rate of 82/min, and respiratory rate of 14/min. Physical examination reveals mild left adnexal tenderness on palpation but no cervical motion tenderness or palpable masses. The cervical os is closed, and there is no active bleeding in the vaginal vault. A serum quantitative β\beta-human chorionic gonadotropin (β\beta-hCG) level is 950950 mIU/mL. Transvaginal ultrasonography demonstrates a thickened endometrial stripe of 12 mm without a visible intrauterine gestational sac, no adnexal masses, and no free pelvic fluid. Which of the following is the most appropriate next step in evaluating this patient's condition?

Show answer & explanation

Answer: Repeat serum quantitative β\beta-hCG testing in 48 hours

Answer

Repeat serum quantitative β\beta-hCG testing in 48 hours
This patient is hemodynamically stable with a pregnancy of unknown location (PUL) and a β\beta-hCG level below the ultrasound discriminatory zone (typically 1500-2000 mIU/mL). At this level, it is perfectly normal not to visualize a gestational sac on transvaginal ultrasound for an early viable intrauterine pregnancy. Therefore, the most appropriate next step in the diagnostic sequence is to repeat the quantitative β\beta-hCG in 48 hours. An appropriate rise (typically at least 35-53% in 48 hours) suggests a viable early pregnancy, while a plateau or inappropriate rise raises suspicion for an ectopic or failing pregnancy, guiding further diagnostic and therapeutic steps.

Step-by-Step Solution

1
Identify the patient's clinical stability and primary diagnosis.
The patient is hemodynamically stable with a pregnancy of unknown location (PUL).
Vital signs are normal, and the transvaginal ultrasound shows neither an intrauterine nor an extrauterine pregnancy.
2
Evaluate the quantitative β\beta-hCG level against the discriminatory zone.
The level is 950950 mIU/mL, which is below the standard discriminatory zone of 15001500-20002000 mIU/mL.
The discriminatory zone is the β\beta-hCG threshold above which a normal intrauterine gestational sac should consistently be visible on transvaginal ultrasound.
3
Determine the guideline-directed next step in test sequencing.
Repeat the quantitative β\beta-hCG level in 48 hours.
Because the level is below the discriminatory zone, an early viable pregnancy cannot be ruled out. Serial tracking is required to observe the β\beta-hCG trend before pursuing invasive testing or medical termination.

Key Concept

In a hemodynamically stable patient with a pregnancy of unknown location and a β\beta-hCG level below the discriminatory zone, the optimal next diagnostic step is serial β\beta-hCG tracking in 48 hours to distinguish between an early viable intrauterine pregnancy, an ectopic pregnancy, and an early pregnancy loss.
Question 3346Question →

Emergency medical services transport a 24-year-old male with a known history of severe persistent asthma to the acute care bay. According to his roommate, the patient experienced progressively worsening shortness of breath over the past 24 hours and had been using his albuterol inhaler continuously with no clinical improvement. Upon evaluation, the patient is obtunded, profoundly diaphoretic, and cannot answer questions or follow commands. His vital signs show a temperature of 37.1°C, heart rate of 145/min, blood pressure of 112/68 mmHg, and a decreasing respiratory rate of 8/min with shallow excursions. Pulse oximetry reads 85% despite high-flow supplemental oxygen via a non-rebreather mask. Auscultation of the lungs reveals a 'silent chest' with markedly diminished air movement and no audible wheezing bilaterally. Which of the following is the most appropriate immediate next step in the stabilization of this patient?

Show answer & explanation

Answer: Perform endotracheal intubation and mechanical ventilation

Answer

Perform endotracheal intubation and mechanical ventilation
This patient is exhibiting classic signs of impending respiratory failure secondary to severe status asthmaticus. The combination of altered mental status (obtundation), a falling respiratory rate (8/min), refractory hypoxemia on high-flow oxygen, and a 'silent chest' indicates severe bronchospasm preventing meaningful air exchange and rapid respiratory muscle fatigue. According to the ABCs (Airway, Breathing, Circulation) of resuscitation, he can no longer maintain adequate ventilation independently. Endotracheal intubation is the definitive and most urgent step required to restore oxygenation, provide ventilatory support, and prevent an imminent cardiac arrest.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation and vital signs to determine the severity of the asthma exacerbation.
The patient is obtunded, bradypneic (respiratory rate of 8/min), hypoxemic despite high-flow oxygen, and has a 'silent chest'.
These findings are classic indicators of impending respiratory failure and imminent cardiac arrest, signaling that the patient can no longer maintain adequate ventilation.
2
Apply the principles of primary survey (Airway, Breathing, Circulation) to prioritize interventions.
Airway and breathing are severely compromised and require immediate securing before any other diagnostic or therapeutic step.
According to advanced life support protocols, securing a failing airway takes precedence over imaging, laboratory testing, or standard pharmacologic therapy.
3
Select the most appropriate definitive airway management strategy.
Endotracheal intubation and mechanical ventilation is chosen.
Noninvasive methods are contraindicated due to the patient's altered mental status, and medical therapy will not act fast enough to prevent asphyxiation.

Key Concept

In patients with status asthmaticus presenting with signs of impending respiratory arrest (altered mental status, bradypnea, 'silent chest', and refractory hypoxemia), immediate airway stabilization via endotracheal intubation must be performed before diagnostic testing or continued medical therapy.
Question 3347Question →

An emergency medical services team brings a 64-year-old man to the resuscitation bay due to sudden-onset, agonizing chest pain that he describes as 'ripping' and radiating directly to his shoulder blades. The pain started abruptly one hour ago while he was carrying groceries. He has a known history of tobacco use and medication nonadherence for hypertension. The patient is visibly distressed, sweating profusely, and unable to find a comfortable position on the stretcher.

Vital signs:
Temperature: 37.1°C (98.8°F)
Blood pressure: 220/120 mm Hg in the right arm, 175/90 mm Hg in the left arm
Heart rate: 118/min
Respiratory rate: 24/min
Oxygen saturation: 97% on room air

An electrocardiogram demonstrates sinus tachycardia with left ventricular hypertrophy but no ST-segment or T-wave abnormalities. A stat portable chest radiograph shows a widened mediastinum.

Which of the following is the most appropriate immediate next step in the management of this patient?

Show answer & explanation

Answer: Administer intravenous esmolol

Answer

Administer intravenous esmolol
The patient's presentation of sudden-onset, tearing chest pain radiating to the back, asymmetric blood pressures, and a widened mediastinum on chest radiograph is highly suggestive of an acute aortic dissection. The immediate priority in the management of suspected aortic dissection is hemodynamic stabilization to prevent further propagation of the intimal tear and potential aortic rupture. This requires strict reduction of aortic wall shear stress (dP/dtdP/dt). Intravenous beta-blockers, such as esmolol or labetalol, decrease both the heart rate (target < 60/min) and the force of left ventricular contractility. These agents are the most appropriate first-line therapy and must be administered immediately upon clinical suspicion, prior to sending the patient for definitive diagnostic imaging.

Step-by-Step Solution

1
Evaluate the clinical presentation and vital signs.
The patient has tearing chest pain radiating to the back, asymmetric blood pressures, severe hypertension, tachycardia, and a widened mediastinum.
These findings are highly suspicious for an acute aortic dissection.
2
Determine the primary goal of immediate management.
The most urgent priority is to halt the progression of the dissection by reducing the shearing forces on the aortic wall.
Elevated heart rate and blood pressure increase aortic wall shear stress (dP/dtdP/dt), which can cause the dissection to propagate or rupture.
3
Select the appropriate initial pharmacologic intervention.
Intravenous beta-blockers (e.g., esmolol or labetalol) should be administered immediately.
Beta-blockers decrease both the heart rate and the force of left ventricular contraction, effectively lowering dP/dtdP/dt and stabilizing the patient for subsequent definitive imaging.

Key Concept

In patients with suspected acute aortic dissection, the immediate next step in management is hemodynamic stabilization with intravenous beta-blockers to reduce heart rate and blood pressure before definitive imaging is performed.
Estimated Time:1m 0s
Question 3348Question →

A 7171-year-old female presents to the cardiology clinic for an urgent consultation regarding worsening shortness of breath and ankle swelling over the past 66 weeks. She reports needing three pillows to sleep at night and becomes breathless after walking just one block. Her past medical history is notable for seropositive rheumatoid arthritis, type 2 diabetes mellitus, essential hypertension, and stage 4 chronic kidney disease. Her medication regimen includes oral methotrexate, subcutaneous adalimumab, metformin, sitagliptin, and lisinopril.

Vital signs show a blood pressure of 134/82 mmHg134/82 \text{ mmHg} and a heart rate of 88 /min88\text{ /min}. Physical examination reveals distended jugular veins, crackles in the lower third of both lung fields, and bilateral 2+2+ pitting edema up to the mid-calves.

A transthoracic echocardiogram reveals global hypokinesis with an estimated left ventricular ejection fraction of 25%25\%.

Current laboratory values:
Serum potassium: 4.6 mEq/L4.6 \text{ mEq/L}
Serum creatinine: 2.5 mg/dL2.5 \text{ mg/dL} (estimated GFR: 22 mL/min/1.73 m222 \text{ mL/min/}1.73 \text{ m}^2; baseline 33 months ago: 2.4 mg/dL2.4 \text{ mg/dL})
Hemoglobin A1c: 7.2%7.2\%

Which of the following sets of modifications to this patient's current medications is most appropriate?

Show answer & explanation

Answer: Discontinuation of adalimumab and metformin

Answer

The most appropriate modification is the discontinuation of both adalimumab and metformin.
The correct action addresses the two most critical and absolute pharmacologic contraindications in this patient's presentation. First, adalimumab is a TNF-alpha inhibitor. The use of TNF-alpha inhibitors in patients with New York Heart Association (NYHA) class III or IV heart failure is contraindicated because they have been shown to exacerbate heart failure and increase mortality. Second, the patient's estimated GFR has declined to 22 mL/min/1.73 m². Metformin is absolutely contraindicated in patients with an eGFR < 30 mL/min/1.73 m² due to an unacceptably high risk of developing metformin-associated lactic acidosis. Both medications must be stopped immediately.

Step-by-Step Solution

1
Identify the patient's new acute clinical syndrome and synthesize it with her chronic conditions.
The patient has new-onset heart failure with reduced ejection fraction (HFrEF) presenting as NYHA Class III symptoms (LVEF 25%, orthopnea, edema). She also has Stage 4 chronic kidney disease (CKD) with an eGFR of 22 mL/min/1.73 m².
Accurate identification of the intersection of new diagnoses with underlying chronic organ dysfunction is required before evaluating pharmacologic safety.
2
Evaluate the patient's current rheumatoid arthritis therapy (adalimumab, methotrexate) against the new HFrEF diagnosis.
Adalimumab must be discontinued.
Tumor necrosis factor (TNF)-alpha inhibitors are known to worsen heart failure and are absolutely contraindicated in patients with moderate to severe (NYHA class III or IV) heart failure.
3
Evaluate the patient's current diabetes therapy (metformin, sitagliptin) against her current renal function.
Metformin must be discontinued.
Metformin carries a black box warning for lactic acidosis in severe renal impairment and is contraindicated when the eGFR falls below 30 mL/min/1.73 m².
4
Evaluate the safety of continuing the ACE inhibitor (lisinopril) given her elevated creatinine.
Lisinopril should be continued.
The patient's creatinine of 2.5 mg/dL is stable compared to her baseline of 2.4 mg/dL, and her potassium is normal (4.6 mEq/L). ACE inhibitors provide a significant mortality benefit in HFrEF and should not be stopped for stable CKD.

Key Concept

Polypharmacy management requires routine reassessment for contraindications, specifically avoiding TNF-alpha inhibitors in severe heart failure, avoiding metformin in severe chronic kidney disease (eGFR < 30), and ensuring proper washout periods between ACE inhibitors and ARNIs.
Estimated Time:2m 0s
Question 3349Question →

A 3232-year-old female fitness instructor is evaluated for a 44-week history of heart palpitations, severe anxiety, heat intolerance, and excessive sweating. She reports strict adherence to a new competition diet and taking various over-the-counter supplements for "cutting weight." Blood pressure is 145/88145/88 mm Hg, and pulse is 118118/min. Physical examination shows a fine resting tremor in both hands and hyperreflexia. The thyroid gland is non-palpable and non-tender. There is no proptosis, periorbital edema, or pretibial myxedema.

Laboratory evaluation shows the following:

TestResultReference Range
Thyroid-stimulating hormone (TSH)<0.01< 0.01 μ\muU/mL0.4−4.00.4 - 4.0 μ\muU/mL
Free thyroxine (T4)0.30.3 ng/dL0.8−1.80.8 - 1.8 ng/dL
Total triiodothyronine (T3)350350 ng/dL80−20080 - 200 ng/dL
Thyroglobulin<0.5< 0.5 ng/mL3−403 - 40 ng/mL
Thyrotropin receptor antibodiesNegativeNegative

Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Exogenous triiodothyronine (T3) ingestion

Answer

Exogenous triiodothyronine (T3) ingestion
This patient presents with clinical thyrotoxicosis and a suppressed TSH, indicating primary hyperthyroidism or exogenous intake. The critical distinguishing laboratory findings are the paradoxically low free T4 alongside an elevated total T3 and an undetectable thyroglobulin level. Endogenous production of thyroid hormone involves the synthesis of both T4 and T3, as well as the byproduct thyroglobulin. If the patient were hyperthyroid from an endogenous overactive gland (e.g., Graves disease) or destructive thyroiditis, thyroglobulin would be elevated. An undetectable thyroglobulin level points exclusively to an exogenous source, as the suppressed TSH turns off endogenous thyroid gland activity (and thus thyroglobulin production). The specific pattern of low T4 and high T3 indicates that the patient is ingesting pure triiodothyronine (T3, such as liothyronine or certain weight-loss supplements), rather than levothyroxine (T4), which would elevate free T4.

Step-by-Step Solution

1
Interpret the thyroid function test pattern.
The patient has thyrotoxicosis with a suppressed TSH, elevated T3, but a paradoxically low free T4.
Establishing the specific pattern of circulating hormones is the first step in differentiating the causes of thyrotoxicosis.
2
Analyze the thyroglobulin level in the context of thyrotoxicosis.
The thyroglobulin level is undetectable (< 0.5 ng/mL).
Thyroglobulin is a byproduct of endogenous thyroid hormone synthesis. An undetectable level in a thyrotoxic patient confirms an exogenous hormone source, ruling out endogenous overproduction or destructive thyroiditis.
3
Synthesize the hormone pattern to identify the specific exogenous agent.
The combination of low T4 and high T3 points to pure exogenous T3 ingestion.
Exogenous T3 suppresses TSH, which in turn halts the endogenous thyroid gland's production of T4, explaining the low free T4 level.

Key Concept

Factitious thyrotoxicosis from T3 ingestion presents with suppressed TSH, elevated T3, paradoxically low T4, and an undetectable thyroglobulin level.
Question 3350Question →

A 3434-year-old man arrives at the trauma bay via helicopter emergency medical services after a high-speed motorcycle collision. He is agitated, pale, and diaphoretic. Vital signs show a blood pressure of 74/4074/40 mm Hg, a heart rate of 145145/min, and a respiratory rate of 3636/min. His oxygen saturation is 86%86\% despite receiving high-flow oxygen via a nonrebreather mask. Clinical evaluation demonstrates rightward tracheal deviation and absent breath sounds over the left hemithorax, which is hyperresonant to percussion. An anteroposterior compression force on the iliac crests reveals marked pelvic instability. Peripheral intravenous access has just been established. Which of the following simultaneous interventions are the most appropriate immediate next steps in management? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Perform a left-sided needle or finger thoracostomy; Initiate transfusion of uncrossmatched type O blood; Apply a circumferential pelvic binder

Answer

The most appropriate immediate next steps are performing a left-sided thoracostomy, initiating an uncrossmatched blood transfusion, and applying a circumferential pelvic binder.
This patient presents with highly unstable polytrauma, exhibiting both obstructive shock from a left-sided tension pneumothorax and hypovolemic (hemorrhagic) shock likely driven by an unstable pelvic fracture. According to Advanced Trauma Life Support (ATLS) principles, the primary survey focuses on immediate resuscitation of the airway, breathing, and circulation (ABCs). The tension pneumothorax must be decompressed immediately with a needle or finger thoracostomy to resolve the obstructive physiology. Simultaneously, severe hemorrhagic shock requires aggressive volume resuscitation with uncrossmatched blood products (such as type O blood) and mechanical stabilization of the bleeding source, achieved here by applying a circumferential pelvic binder. These life-saving steps must occur in tandem during the initial minutes of resuscitation.

Step-by-Step Solution

1
Identify the immediately life-threatening conditions present in the primary survey.
The patient exhibits signs of a left-sided tension pneumothorax (tracheal deviation, absent breath sounds, hyperresonance) and severe hemorrhagic shock (hypotension, tachycardia, unstable pelvis).
Recognizing acute threats to life dictates the priority of trauma interventions.
2
Determine the appropriate interventions to stabilize the airway and breathing.
A left-sided needle or finger thoracostomy is required immediately.
Tension pneumothorax causes obstructive shock and hypoxia, which must be relieved to restore venous return and adequate oxygenation.
3
Determine the appropriate interventions to stabilize circulation.
Initiation of uncrossmatched blood transfusion and application of a pelvic binder are necessary.
Hemorrhagic shock from an unstable pelvic fracture requires immediate volume replacement and mechanical tamponade of bleeding.

Key Concept

In acute polytrauma, the primary survey focuses on identifying and simultaneously treating life-threatening conditions (ABCs) such as tension pneumothorax and hemorrhagic shock before proceeding to advanced diagnostic imaging.
Estimated Time:1m 30s
Question 3351Question →

A 34-year-old male patient presents for an initial primary care evaluation to establish care. He reports feeling entirely well and has no specific health concerns. He denies headaches, palpitations, diaphoresis, or muscle weakness. He takes no medications and does not use tobacco or illicit drugs. Family history is notable for type 2 diabetes in his father, but no early-onset cardiovascular disease. His blood pressure is 166/104 mmHg. A repeat measurement after 15 minutes of rest is 164/102 mmHg. Physical examination reveals a body mass index (BMI) of 23.5 kg/m 2^2. The abdomen is soft without bruits, and there are no abnormal skin findings or fat redistribution.

Laboratory studies are obtained with the following results:

Laboratory ParameterResultReference Range
Sodium143 mEq/L136-145 mEq/L
Potassium3.1 mEq/L3.5-5.0 mEq/L
Chloride102 mEq/L98-106 mEq/L
Bicarbonate29 mEq/L22-28 mEq/L
Blood urea nitrogen14 mg/dL8-20 mg/dL
Creatinine0.8 mg/dL0.7-1.3 mg/dL

Arrange the following differential diagnoses in order from HIGHEST pre-test probability to LOWEST pre-test probability based on this patient's clinical presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from highest to lowest pre-test probability is: Primary hyperaldosteronism, Renovascular hypertension, Cushing syndrome, and Pheochromocytoma.
Evaluating secondary hypertension requires integrating laboratory findings with patient demographics. The patient has unprovoked hypokalemia and mild metabolic alkalosis. Primary hyperaldosteronism is the textbook cause of this triad (hypertension, hypokalemia, alkalosis) in an otherwise healthy young adult, making it the most likely diagnosis. Renovascular disease is a strong secondary consideration as it mimics this physiology via the renin-angiotensin-aldosterone system, but it is epidemiologically discordant for a young male without an abdominal bruit. Cushing syndrome is ranked lower due to a complete lack of physical exam findings (no central obesity or striae), and pheochromocytoma is ranked lowest as it does not physiologically explain the electrolyte derangements and lacks the classic paroxysmal symptoms.

Step-by-Step Solution

1
Analyze the patient's objective data and demographic profile.
The patient is a young, healthy male with severe asymptomatic hypertension, spontaneous hypokalemia (3.1 mEq/L), and mild metabolic alkalosis (Bicarbonate 29 mEq/L).
Identifying the core triad of hypertension, hypokalemia, and alkalosis narrows the differential to conditions affecting the mineralocorticoid axis.
2
Prioritize diagnoses that directly explain the electrolyte derangements.
Primary hyperaldosteronism perfectly matches the unprovoked hypokalemia and alkalosis. Renovascular disease can mimic this via secondary hyperaldosteronism.
Direct mineralocorticoid excess drives renal potassium wasting and hydrogen ion excretion.
3
Use epidemiological data and negative physical exam findings to further stratify the differential.
Renovascular disease is lowered in probability due to the patient's demographics (young male, no bruit). Cushing syndrome is lowered due to the absence of physical stigmata. Pheochromocytoma is ranked lowest as it does not cause hypokalemia and the patient lacks paroxysmal symptoms.
Pre-test probability depends not just on physiological possibility, but on population demographics and the presence or absence of classic clinical hallmarks.

Key Concept

Prioritizing the differential diagnosis for secondary hypertension based on metabolic derangements (hypokalemia, alkalosis) and demographic risk factors.
Estimated Time:1m 30s
Question 3352Question →

A 38-year-old man is admitted to the hospital for intravenous antibiotic therapy for right lower extremity cellulitis. His past medical history is significant for treatment-resistant schizophrenia, which has been well-controlled for three years on a stable dose of clozapine (500 mg daily). He smokes two packs of cigarettes per day. Because the hospital is a smoke-free facility, he is prescribed a 21-mg nicotine transdermal patch upon admission to prevent withdrawal symptoms. His admission laboratory studies, including a serum creatinine of 0.8 mg/dL and normal liver enzymes, are unremarkable. He is started on intravenous daptomycin. On hospital day 4, the patient experiences a first-time generalized tonic-clonic seizure. Vital signs immediately following the event are temperature 37.0°C (98.6°F), blood pressure 132/82 mmHg, heart rate 94/min, and respiratory rate 16/min. Neurologic examination demonstrates post-ictal confusion but no focal deficits.

Which of the following medication management strategies upon admission would have most likely prevented this patient's new-onset neurologic complication?

Show answer & explanation

Answer: Decrease the daily dosage of clozapine by 30% to 50%

Answer

Decrease the daily dosage of clozapine by 30% to 50%
The correct intervention is to decrease the daily dosage of clozapine by 30% to 50%. Clozapine is heavily metabolized by the hepatic cytochrome P450 1A2 (CYP1A2) enzyme. Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs), which are potent inducers of CYP1A2. In heavy smokers, this induction increases clozapine clearance, requiring higher maintenance doses to achieve therapeutic efficacy. When a patient is admitted to a smoke-free environment, the sudden cessation of PAH exposure leads to a rapid decline in CYP1A2 activity over a few days. Consequently, clozapine metabolism slows, and serum levels can double or triple, leading to dose-dependent adverse effects such as generalized tonic-clonic seizures. Preemptively reducing the clozapine dose upon admission is necessary to prevent this life-threatening toxicity.

Step-by-Step Solution

1
Identify the cause of the patient's new-onset seizure.
The seizure is due to clozapine toxicity.
Clozapine lowers the seizure threshold in a dose-dependent manner. The patient's hospitalization in a smoke-free facility caused a sudden pharmacokinetic shift.
2
Analyze the mechanism of the pharmacokinetic shift.
Loss of polycyclic aromatic hydrocarbons (PAHs) led to decreased CYP1A2 activity.
Tobacco smoke contains PAHs, which strongly induce CYP1A2. Sudden cessation of PAH exposure leads to a rapid rise in serum levels of clozapine, a major CYP1A2 substrate.
3
Determine the appropriate preventive intervention.
The clozapine dose must be empirically reduced upon admission to a smoke-free facility.
A preemptive dose reduction of 30% to 50% accounts for the loss of enzyme induction and prevents dose-dependent toxicity.
4
Evaluate alternative options for contraindications.
Carbamazepine and bupropion are contraindicated.
Carbamazepine increases agranulocytosis risk; bupropion further lowers the seizure threshold.

Key Concept

Patients stabilized on clozapine require a preemptive dose reduction of 30% to 50% when admitted to a smoke-free environment to prevent toxicity (e.g., seizures) caused by the sudden loss of CYP1A2 induction from tobacco smoke.
Question 3353Question →

For each of the following patient encounters, identify the specific ethical doctrine or decision-making standard that appropriately justifies the clinical action taken.

Click a left item, then click its matching right item

Items

An adult child declines a feeding tube for their comatose father, citing the father's previous casual statements that he would 'never want to be kept alive by tubes if there was no hope of waking up.'
A state-appointed guardian authorizes an urgent cholecystectomy for a nonverbal adult ward who has had profound, lifelong cognitive impairment.
A patient facing a high-risk bypass graft explicitly asks the cardiovascular surgeon not to explain the potential complications, requesting that all details be discussed only with their spouse.
An attending physician temporarily delays disclosing a terminal diagnosis to a hospitalized patient who is currently being physically stabilized following a severe, acute suicide attempt.

Matches

Show answer & explanation

Answer

The scenarios match to their respective ethical standards as follows: the adult child acting on previous statements illustrates the substituted judgment standard; the guardian acting for a lifelong impaired patient illustrates the best interests standard; the patient declining information illustrates a waiver of informed consent; and delaying disclosure due to immediate self-harm risk illustrates therapeutic privilege.
Each scenario illustrates a distinct doctrine in medical ethics. Substituted judgment applies when a surrogate uses the known values of a formerly capable patient. Best interests applies when the patient's values are unknown or they never possessed capacity. A waiver occurs when a patient explicitly asks not to be informed. Therapeutic privilege allows a physician to withhold information if disclosure would cause severe, immediate psychological harm.

Step-by-Step Solution

1
Analyze the decision-making basis for the comatose father.
The surrogate uses the patient's prior casual statements to guide care.
This dictates the substituted judgment standard, which relies on known preferences of a formerly capable patient.
2
Evaluate the standard used for the patient who lacked capacity since birth.
The guardian authorizes surgery without knowing any prior patient preferences.
This requires the best interests standard, utilized when a patient's values are unknown or they never had decision-making capacity.
3
Determine the ethical principle when the patient actively declines to hear surgical risks.
The patient delegates the information reception to their spouse.
This represents a valid waiver of informed consent, an exercise of patient autonomy.
4
Identify the justification for withholding the terminal diagnosis in the final scenario.
The physician delays disclosure to prevent an immediate suicide attempt.
This is a rare but valid application of therapeutic privilege, intended to prevent acute and severe harm.

Key Concept

Standards of surrogate decision-making and exceptions to informed consent
Question 3354Question →

A 45-year-old man comes to the clinic for a follow-up visit after being diagnosed with active pulmonary tuberculosis. Sputum acid-fast bacilli smear and culture were positive for Mycobacterium tuberculosis, and he has been started on appropriate four-drug therapy. During the visit, the patient expresses significant anxiety about his diagnosis. He explicitly requests that his medical information not be shared with anyone, particularly government or local authorities, because he fears it will negatively impact his employment. Which of the following is the most appropriate response to this patient's request?

Show answer & explanation

Answer: Inform the patient that the diagnosis must be reported to the local public health department

Answer

Inform the patient that the diagnosis must be reported to the local public health department.
Physicians have a legal and ethical obligation to report specific communicable diseases, including active tuberculosis, to local or state public health departments. This mandatory reporting is necessary to initiate contact tracing, ensure adequate treatment, and prevent the spread of the disease within the community. When mandatory reporting laws apply, they legally supersede the patient's right to confidentiality. The most appropriate action is to compassionately but clearly inform the patient of this legal requirement rather than making false promises of strict secrecy.

Step-by-Step Solution

1
Identify the patient's diagnosis and its public health implications.
The patient has active pulmonary tuberculosis, a highly contagious and dangerous infectious disease.
Establishing the specific diagnosis determines whether mandatory reporting laws apply.
2
Determine the legal reporting requirements for this condition.
Active tuberculosis is a universally mandatory reportable disease across all jurisdictions.
State and local laws require healthcare providers to report certain communicable diseases to protect public health.
3
Address the patient's request for confidentiality.
The physician must tell the patient that the law requires reporting the diagnosis to the health department.
Mandatory reporting laws legally supersede the physician's standard duty to maintain patient confidentiality.

Key Concept

Mandatory reporting of highly communicable infectious diseases
Estimated Time:45s
Question 3355Question →

A retired 6868-year-old teacher presents to the emergency department reporting two days of profound fatigue and noticeably reduced urine volume. Four days ago, he underwent an urgent percutaneous coronary intervention with stent placement for a non-ST-segment elevation myocardial infarction. He was discharged the following day in stable condition. His medical history is notable for hypertension, type 2 diabetes mellitus, and hyperlipidemia. Current medications are aspirin, clopidogrel, atorvastatin, and metoprolol.

His temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 158/92 mmHg158/92\text{ mmHg}, and pulse is 84/min84/\text{min}. Physical examination reveals a lacy, purplish discoloration in a reticular pattern over his bilateral thighs and lower legs that does not blanch with pressure. The toes on his right foot appear cyanotic, although bilateral dorsalis pedis and posterior tibial pulses are strong and symmetric.

Laboratory studies show:
- Hemoglobin: 13.2 g/dL13.2\text{ g/dL}
- Platelet count: 210,000/μL210,000/\mu\text{L}
- Leukocyte count: 10,500/μL10,500/\mu\text{L} (Neutrophils 65%65\%, Lymphocytes 25%25\%, Eosinophils 10%10\%)
- Blood urea nitrogen: 48 mg/dL48\text{ mg/dL}
- Serum creatinine: 2.9 mg/dL2.9\text{ mg/dL} (baseline prior to the procedure was 1.1 mg/dL1.1\text{ mg/dL})
- Urinalysis: 1−2 RBCs/hpf1-2\text{ RBCs/hpf}, trace protein, and positive for urinary eosinophils.

Based on these clinical and laboratory findings, which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Cholesterol atheroembolism

Answer

Cholesterol atheroembolism
The correct diagnosis is cholesterol atheroembolism (also known as cholesterol crystal embolization). During invasive vascular procedures like cardiac catheterization, mechanical trauma can scrape atherosclerotic plaques off the aortic wall. These cholesterol crystals shower downstream into small arterioles, causing microvascular occlusion and an intense inflammatory reaction. The classic presentation includes acute kidney injury (often developing days to weeks after the procedure, later than contrast nephropathy), livedo reticularis, and "blue toe syndrome" where toes become cyanotic despite intact palpable distal pulses (as the occlusion is microvascular). The inflammatory response to the crystals frequently triggers both peripheral eosinophilia and eosinophiluria, which often misleads clinicians toward acute interstitial nephritis.

Step-by-Step Solution

1
Analyze the timeline and triggering event.
The patient developed acute kidney injury and systemic symptoms 44 days after an invasive vascular procedure (percutaneous coronary intervention).
Establishing the temporal relationship between a procedure and symptom onset is the first step in formulating a differential diagnosis for hospital-associated complications.
2
Evaluate the physical examination findings.
The patient has livedo reticularis (lacy, purplish rash) and blue toes, but importantly, his distal pedal pulses are strong and intact.
Intact pulses in the setting of distal ischemia strongly suggest microvascular occlusion (capillaries/arterioles) rather than a macrovascular thrombosis or saddle embolus.
3
Interpret the laboratory data in context.
The patient has worsening acute kidney injury accompanied by peripheral eosinophilia (10%10\%) and urinary eosinophils.
While eosinophiluria is classically taught as a marker for acute interstitial nephritis, it is also a well-documented hallmark of the inflammatory response to cholesterol crystals in atheroembolic disease.
4
Synthesize findings to isolate the most likely diagnosis.
The combination of recent vascular instrumentation, delayed-onset acute kidney injury, livedo reticularis, blue toes with intact pulses, and eosinophilia definitively points to cholesterol atheroembolism.
No other differential diagnosis adequately explains both the microvascular skin findings and the specific allergic-type inflammatory laboratory profile following catheterization.

Key Concept

Cholesterol atheroembolism is a multisystem complication of vascular procedures characterized by delayed acute kidney injury, livedo reticularis, blue toe syndrome with intact pulses, and a prominent eosinophilic inflammatory response.
Estimated Time:1m 30s
Question 3356Question →

Match each patient's clinical presentation with the most likely underlying neurologic diagnosis.

Click a left item, then click its matching right item

Items

A 55-year-old man presents with progressive weakness in his right hand. Examination reveals muscle atrophy in the right intrinsic hand muscles, fasciculations in the tongue, and brisk reflexes in both lower extremities. Sensory examination is completely normal.
A 35-year-old woman presents with leg weakness that has been worsening over three days. Examination shows symmetric lower extremity weakness and absent patellar and Achilles reflexes. She reports having a severe diarrheal illness two weeks ago.
A 28-year-old man presents with the inability to move his legs and urinary retention developing rapidly over 24 hours. Examination reveals flaccid paraplegia and a distinct loss of pinprick sensation below the level of the umbilicus.
A 72-year-old woman with a history of autoimmune gastritis presents with progressive unsteadiness. Examination shows symmetric upper motor neuron signs in the legs and markedly diminished position and vibratory sensation in the toes.

Matches

Show answer & explanation

Answer

Patient 1 matches Amyotrophic lateral sclerosis; Patient 2 matches Guillain-Barré syndrome; Patient 3 matches Transverse myelitis; Patient 4 matches Subacute combined degeneration.
Each clinical vignette isolates a classic neurological presentation by manipulating key physical exam findings—specifically reflex tone, sensory involvement, and temporal history. The correct matching aligns the precise neuroanatomical deficits with the pathophysiology of the specific disease process.

Step-by-Step Solution

1
Analyze the first patient's symptom profile.
The patient has both upper motor neuron (brisk reflexes) and lower motor neuron (atrophy, fasciculations) signs with a normal sensory exam.
Identifying pure motor involvement with mixed upper and lower motor neuron signs narrows the differential directly to amyotrophic lateral sclerosis.
2
Analyze the second patient's symptom profile.
The patient has ascending symmetric weakness, areflexia, and a recent history of a gastrointestinal illness.
Recognizing the post-infectious (often Campylobacter jejuni) timeline combined with purely peripheral demyelination (areflexia) establishes a diagnosis of Guillain-Barré syndrome.
3
Analyze the third patient's symptom profile.
The patient has rapidly progressive paraplegia, autonomic dysfunction, and a clear sensory level at the umbilicus.
A distinct sensory level combined with sudden motor and autonomic deficits requires localization to the spinal cord, making transverse myelitis the most likely differential among the choices.
4
Analyze the fourth patient's symptom profile.
The patient has combined posterior column (vibration/proprioception) and lateral corticospinal tract (upper motor neuron) dysfunction, alongside a history of autoimmune gastritis.
Correlating the patient's risk for Vitamin B12 deficiency (due to pernicious anemia) with the classic neurological presentation solidifies the diagnosis of subacute combined degeneration.

Key Concept

Formulating a differential diagnosis for acute and subacute neurological weakness requires precise anatomical localization utilizing sensory levels, reflex status, and temporal disease progression.
Question 3357Question →

During multidisciplinary rounds, the care team is planning the next steps for a patient who recently underwent an emergent colectomy for perforated diverticulitis. The patient, a retired teacher, has been hospitalized for two weeks. Acute infectious processes have resolved, and intravenous antibiotics were discontinued yesterday. Vital signs are currently within normal limits.

The physical therapy team notes that the patient experiences significant fatigue, tolerating only 40 minutes of low-intensity mobilization exercises before needing to rest for the remainder of the day. Prior to admission, the patient lived independently with a spouse. Currently, the patient requires moderate physical assistance for bed-to-chair transfers and is unable to safely ambulate. Additionally, the patient has a newly formed stoma; the spouse is eager to assist but has not yet demonstrated competency in ostomy appliance changes despite repetitive nursing instruction.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Skilled nursing facility

Answer

Skilled nursing facility
The most appropriate disposition is a skilled nursing facility (SNF). This patient requires continued physical therapy and skilled nursing care for a new ostomy. However, because the patient can only tolerate 40 minutes of physical therapy daily, they do not qualify for an inpatient rehabilitation facility (IRF), which requires tolerance of at least 3 hours of therapy per day. Furthermore, the patient is unsafe to be discharged home because they require moderate assistance with transfers, and the spouse is not yet competent to manage the ostomy independently.

Step-by-Step Solution

1
Evaluate the patient's acute medical needs.
The acute infection has resolved, IV antibiotics are complete, and vitals are stable.
This establishes that the patient no longer requires an acute care hospital or a long-term acute care hospital (LTACH).
2
Assess functional status and therapy tolerance.
The patient requires moderate assistance with transfers and only tolerates 40 minutes of therapy per day.
This rules out an inpatient rehabilitation facility (IRF), which strictly requires patients to tolerate at least 3 hours of therapy daily.
3
Evaluate skilled nursing needs and caregiver support.
The patient needs ostomy care teaching and transfer assistance that the spouse cannot safely provide at home yet.
This rules out a safe discharge to home with home health services, as the 24-hour care needs exceed the capabilities of the current home environment.
4
Determine the most appropriate facility based on the combined needs.
A skilled nursing facility (SNF) is chosen.
An SNF bridges the gap by providing 24-hour nursing care (ostomy management), lower-intensity physical therapy, and assistance with activities of daily living.

Key Concept

Appropriate care setting transitions rely on matching a patient's medical stability, functional therapy tolerance, and caregiver support with specific facility admission criteria (e.g., SNF vs. IRF vs. Home).
Question 3358Question →

A 55-year-old man is hospitalized for the treatment of community-acquired pneumonia. The attending physician orders intravenous ceftriaxone. The following morning, the physician is notified by the charge nurse that the patient mistakenly received an intravenous infusion of cefazolin instead of ceftriaxone due to a mislabeled intravenous bag delivered from the hospital pharmacy. The patient has no known drug allergies, remains hemodynamically stable, and shows no adverse clinical signs or symptoms from the incorrect medication administration. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Inform the patient about the medication error and explain the steps being taken to investigate and prevent it from recurring

Answer

Inform the patient about the medication error and explain the steps being taken to investigate and prevent it from recurring.
The correct action is to promptly inform the patient about the medication error. According to medical ethics and professionalism standards, physicians have a fiduciary duty to disclose all medical errors to patients, including those that do not result in clinical harm. A full disclosure includes explaining what happened, answering the patient's questions, apologizing, and explaining the systemic steps that will be taken to investigate the root cause and prevent future occurrences. This transparent approach fosters trust, respects patient autonomy, and is a fundamental component of patient safety culture.

Step-by-Step Solution

1
Evaluate the clinical status of the patient following the medical error.
The patient is hemodynamically stable and has suffered no adverse effects.
The first priority in any medical error is ensuring patient safety and providing immediate stabilizing care if necessary.
2
Identify the ethical and professional obligations regarding the error.
The physician recognizes the duty to disclose the error to the patient.
The American Medical Association (AMA) Code of Medical Ethics requires physicians to fully disclose medical errors to patients, regardless of whether harm occurred.
3
Determine the appropriate communication approach.
The physician plans to promptly and honestly inform the patient about the mistake and the subsequent investigation.
Prompt disclosure maintains the patient's trust, respects their autonomy, and aligns with legal and institutional risk management standards.

Key Concept

Disclosure of Medical Errors
Question 3359Question →

A 68-year-old man is evaluated in the surgical step-down unit due to tachycardia. He was transferred from the intensive care unit (ICU) earlier this morning, which is postoperative day 3 following an open abdominal aortic aneurysm repair. During the morning verbal handoff, the night-shift intensivist told the receiving physician, "The patient had some mild tachycardia overnight, but it is just expected postoperative incisional pain; we plan to optimize his epidural." Upon evaluation 3 hours later, the patient's heart rate is 125/min and blood pressure is 88/58 mmHg. He complains of vague, diffuse abdominal discomfort and back pain. The receiving physician documents, "Tachycardia secondary to inadequately controlled pain," and immediately orders an epidural local anesthetic bolus without reviewing the patient's recent hemoglobin level or ordering new laboratory studies. Later that evening, the patient develops profound hemorrhagic shock due to a retroperitoneal bleed. Which of the following cognitive biases best explains the receiving physician's initial decision-making process?

Show answer & explanation

Answer: Anchoring bias

Answer

Anchoring bias
The correct answer is anchoring bias. Anchoring bias occurs when a clinician relies too heavily on the first piece of information provided (the "anchor") and fails to adequately adjust their thinking when new or contradictory information becomes available. In this scenario, the receiving physician anchored on the night-shift intensivist's diagnosis of "expected postoperative incisional pain." Despite the patient developing new, alarming objective findings (hypotension of 88/58 mmHg and back pain), which strongly suggest a catastrophic complication like retroperitoneal bleeding following an aortic procedure, the physician failed to adjust the differential diagnosis and inappropriately initiated isolated pain management.

Step-by-Step Solution

1
Analyze the clinical scenario to identify the source of the medical error.
The physician ignored new objective findings (hypotension and back pain), incorrectly attributing the tachycardia entirely to pain based on the ICU handoff report.
Identifying the mismatch between the objective clinical data and the physician's documented rationale reveals the underlying cognitive flaw.
2
Differentiate between the provided cognitive biases based on the physician's thought process.
The error stems directly from an inability to move away from an initial piece of provided information (the handoff diagnosis of 'pain').
Distinguishing between cognitive biases requires mapping the specific action (relying on the handoff) to the psychological definition.
3
Match the identified thought process to the correct cognitive bias.
Relying too heavily on an initial diagnostic label and failing to adjust despite contradictory evidence is the definition of anchoring bias.
This confirms the specific cognitive bias driving the diagnostic error.

Key Concept

Identification of specific cognitive biases contributing to diagnostic errors in clinical practice, particularly during transitions of care.
Question 3360Question →

A 68-year-old man is hospitalized for a severe exacerbation of chronic obstructive pulmonary disease and newly diagnosed heart failure with preserved ejection fraction. He has stabilized after 4 days of intravenous diuresis and systemic corticosteroids. The medical team is preparing for his transition out of the acute care hospital. He lives with his daughter, who works during the day. He requires new supplemental oxygen and close monitoring of his fluid status. To minimize the risk of readmission and ensure a safe transition of care, arrange the following discharge planning steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a high-risk patient begins with determining the appropriate disposition setting, followed by medication reconciliation, arranging logistical needs, educating the patient and family, and finally transmitting the transition of care documents to receiving providers.
Safe discharge planning follows a logical progression. The healthcare team must first know where the patient is going (disposition). Next, they must finalize what the medical plan is (medication reconciliation). Then, they coordinate the resources needed to support that plan (appointments and durable medical equipment). Only when the plan is fully constructed can the patient and family be properly educated on it. Finally, the completed plan is formally sent to the next providers in the continuum of care to complete the handoff.

Step-by-Step Solution

1
Determine the optimal post-acute care setting.
The multidisciplinary team assesses the patient's functional status and social support to decide between home care, a rehabilitation center, or another setting.
This establishes the foundation of the discharge plan and dictates all subsequent clinical and logistical needs.
2
Reconcile all medications.
The physician reviews and finalizes the patient's pre-admission, inpatient, and planned discharge medications.
An accurate, updated medication list is required before any logistical planning or patient education can occur.
3
Coordinate logistics, appointments, and equipment.
Early follow-up appointments are scheduled, and supplemental oxygen delivery is arranged.
These logistical elements must be secured based on the finalized medical plan before educating the patient on their post-discharge routine.
4
Educate the patient and caregiver.
The nursing staff uses teach-back methods to review the finalized medications, appointments, and clinical warning signs.
Patients cannot be safely educated until the entire medical and logistical plan is completely finalized to avoid conveying conflicting information.
5
Transmit handoff documents.
The final discharge summary is sent to the primary care physician and outpatient clinical teams.
The receiving providers need the comprehensive, finalized transition plan to assume care safely and prevent readmissions.

Key Concept

Safe transitions of care for high-risk patients require a structured, chronological approach starting with disposition determination and culminating in the handoff of a finalized care plan to outpatient providers.
PreviousPage 168 / 237Next